 | • レポートコード：MRC2-11QY01429 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒトパピローマウイルス（HPV）ワクチンのグローバル市場について調査・分析したレポートです。種類別（2価ワクチン、4価ワクチン）市場規模、用途別（研究所、製薬・バイオテクノロジー企業、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトパピローマウイルス（HPV）ワクチンの競争状況、市場シェア ・世界のヒトパピローマウイルス（HPV）ワクチン市場：種類別市場規模 2015年-2020年（2価ワクチン、4価ワクチン） ・世界のヒトパピローマウイルス（HPV）ワクチン市場：種類別市場規模予測 2021年-2026年（2価ワクチン、4価ワクチン） ・世界のヒトパピローマウイルス（HPV）ワクチン市場：用途別市場規模 2015年-2020年（研究所、製薬・バイオテクノロジー企業、その他） ・世界のヒトパピローマウイルス（HPV）ワクチン市場：用途別市場規模予測 2021年-2026年（研究所、製薬・バイオテクノロジー企業、その他） ・北米のヒトパピローマウイルス（HPV）ワクチン市場分析：米国、カナダ ・ヨーロッパのヒトパピローマウイルス（HPV）ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトパピローマウイルス（HPV）ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトパピローマウイルス（HPV）ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトパピローマウイルス（HPV）ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、GSK、Walvax ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Papillomavirus (HPV) Vaccines Market
The global Human Papillomavirus (HPV) Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Papillomavirus (HPV) Vaccines Scope and Market Size
Human Papillomavirus (HPV) Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus (HPV) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Papillomavirus (HPV) Vaccines market is segmented into
2-Valent Vaccine
4-Valent Vaccine
Segment by Application, the Human Papillomavirus (HPV) Vaccines market is segmented into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regional and Country-level Analysis
The Human Papillomavirus (HPV) Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Papillomavirus (HPV) Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Papillomavirus (HPV) Vaccines Market Share Analysis
Human Papillomavirus (HPV) Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Papillomavirus (HPV) Vaccines business, the date to enter into the Human Papillomavirus (HPV) Vaccines market, Human Papillomavirus (HPV) Vaccines product introduction, recent developments, etc.
The major vendors covered:
Merck
GSK
Walvax
…
1 Study Coverage
1.1 Human Papillomavirus (HPV) Vaccines Product Introduction
1.2 Market Segments
1.3 Key Human Papillomavirus (HPV) Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Papillomavirus (HPV) Vaccines Market Size Growth Rate by Type
1.4.2 2-Valent Vaccine
1.4.3 4-Valent Vaccine
1.5 Market by Application
1.5.1 Global Human Papillomavirus (HPV) Vaccines Market Size Growth Rate by Application
1.5.2 Research & Academic Laboratories
1.5.3 Pharmaceutical & Biotechnology Companies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Papillomavirus (HPV) Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Human Papillomavirus (HPV) Vaccines Revenue 2015-2026
2.1.2 Global Human Papillomavirus (HPV) Vaccines Sales 2015-2026
2.2 Global Human Papillomavirus (HPV) Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Papillomavirus (HPV) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Papillomavirus (HPV) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Papillomavirus (HPV) Vaccines Competitor Landscape by Players
3.1 Human Papillomavirus (HPV) Vaccines Sales by Manufacturers
3.1.1 Human Papillomavirus (HPV) Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Human Papillomavirus (HPV) Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Human Papillomavirus (HPV) Vaccines Revenue by Manufacturers
3.2.1 Human Papillomavirus (HPV) Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Human Papillomavirus (HPV) Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Papillomavirus (HPV) Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Vaccines Revenue in 2019
3.2.5 Global Human Papillomavirus (HPV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Papillomavirus (HPV) Vaccines Price by Manufacturers
3.4 Human Papillomavirus (HPV) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Human Papillomavirus (HPV) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Papillomavirus (HPV) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Human Papillomavirus (HPV) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Papillomavirus (HPV) Vaccines Market Size by Type (2015-2020)
4.1.1 Global Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020)
4.1.2 Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2015-2020)
4.1.3 Human Papillomavirus (HPV) Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Papillomavirus (HPV) Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Papillomavirus (HPV) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Human Papillomavirus (HPV) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Human Papillomavirus (HPV) Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Papillomavirus (HPV) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Papillomavirus (HPV) Vaccines Market Size by Application (2015-2020)
5.1.1 Global Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020)
5.1.2 Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2015-2020)
5.1.3 Human Papillomavirus (HPV) Vaccines Price by Application (2015-2020)
5.2 Human Papillomavirus (HPV) Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Papillomavirus (HPV) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Human Papillomavirus (HPV) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Papillomavirus (HPV) Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Papillomavirus (HPV) Vaccines by Country
6.1.1 North America Human Papillomavirus (HPV) Vaccines Sales by Country
6.1.2 North America Human Papillomavirus (HPV) Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Type
6.3 North America Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Human Papillomavirus (HPV) Vaccines by Country
7.1.1 Europe Human Papillomavirus (HPV) Vaccines Sales by Country
7.1.2 Europe Human Papillomavirus (HPV) Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Type
7.3 Europe Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Papillomavirus (HPV) Vaccines by Region
8.1.1 Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Region
8.1.2 Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Papillomavirus (HPV) Vaccines by Country
9.1.1 Latin America Human Papillomavirus (HPV) Vaccines Sales by Country
9.1.2 Latin America Human Papillomavirus (HPV) Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Type
9.3 Central & South America Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Papillomavirus (HPV) Vaccines by Country
10.1.1 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country
10.1.2 Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Human Papillomavirus (HPV) Vaccines Products Offered
11.1.5 Merck Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description and Business Overview
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Human Papillomavirus (HPV) Vaccines Products Offered
11.2.5 GSK Related Developments
11.3 Walvax
11.3.1 Walvax Corporation Information
11.3.2 Walvax Description and Business Overview
11.3.3 Walvax Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Walvax Human Papillomavirus (HPV) Vaccines Products Offered
11.3.5 Walvax Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Human Papillomavirus (HPV) Vaccines Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Papillomavirus (HPV) Vaccines Market Estimates and Projections by Region
12.1.1 Global Human Papillomavirus (HPV) Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Human Papillomavirus (HPV) Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Human Papillomavirus (HPV) Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Human Papillomavirus (HPV) Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Human Papillomavirus (HPV) Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Human Papillomavirus (HPV) Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Human Papillomavirus (HPV) Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Human Papillomavirus (HPV) Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Human Papillomavirus (HPV) Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Human Papillomavirus (HPV) Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Papillomavirus (HPV) Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Papillomavirus (HPV) Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Papillomavirus (HPV) Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Papillomavirus (HPV) Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Human Papillomavirus (HPV) Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Papillomavirus (HPV) Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Papillomavirus (HPV) Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Papillomavirus (HPV) Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Papillomavirus (HPV) Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Papillomavirus (HPV) Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Papillomavirus (HPV) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Papillomavirus (HPV) Vaccines Market Segments
Table 2. Ranking of Global Top Human Papillomavirus (HPV) Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Papillomavirus (HPV) Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 2-Valent Vaccine
Table 5. Major Manufacturers of 4-Valent Vaccine
Table 6. Global Human Papillomavirus (HPV) Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Human Papillomavirus (HPV) Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Human Papillomavirus (HPV) Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Human Papillomavirus (HPV) Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Papillomavirus (HPV) Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Human Papillomavirus (HPV) Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Papillomavirus (HPV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Papillomavirus (HPV) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus (HPV) Vaccines as of 2019)
Table 15. Human Papillomavirus (HPV) Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Papillomavirus (HPV) Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Papillomavirus (HPV) Vaccines Price (2015-2020) (USD/Unit)
Table 18. Human Papillomavirus (HPV) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Papillomavirus (HPV) Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Human Papillomavirus (HPV) Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Human Papillomavirus (HPV) Vaccines Sales Share by Type (2015-2020)
Table 24. Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Papillomavirus (HPV) Vaccines Revenue Share by Type (2015-2020)
Table 26. Human Papillomavirus (HPV) Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Human Papillomavirus (HPV) Vaccines Sales Share by Application (2015-2020)
Table 29. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Human Papillomavirus (HPV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Human Papillomavirus (HPV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Papillomavirus (HPV) Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Papillomavirus (HPV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Table 69. Merck Corporation Information
Table 70. Merck Description and Major Businesses
Table 71. Merck Human Papillomavirus (HPV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Merck Product
Table 73. Merck Recent Development
Table 74. GSK Corporation Information
Table 75. GSK Description and Major Businesses
Table 76. GSK Human Papillomavirus (HPV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GSK Product
Table 78. GSK Recent Development
Table 79. Walvax Corporation Information
Table 80. Walvax Description and Major Businesses
Table 81. Walvax Human Papillomavirus (HPV) Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Walvax Product
Table 83. Walvax Recent Development
Table 84. Global Human Papillomavirus (HPV) Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 85. Global Human Papillomavirus (HPV) Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 86. Global Human Papillomavirus (HPV) Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 87. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 88. North America: Human Papillomavirus (HPV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 89. North America: Human Papillomavirus (HPV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Europe: Human Papillomavirus (HPV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 91. Europe: Human Papillomavirus (HPV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Asia Pacific: Human Papillomavirus (HPV) Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 93. Asia Pacific: Human Papillomavirus (HPV) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Latin America: Human Papillomavirus (HPV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 95. Latin America: Human Papillomavirus (HPV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Middle East and Africa: Human Papillomavirus (HPV) Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 97. Middle East and Africa: Human Papillomavirus (HPV) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Market Risks
Table 101. Main Points Interviewed from Key Human Papillomavirus (HPV) Vaccines Players
Table 102. Human Papillomavirus (HPV) Vaccines Customers List
Table 103. Human Papillomavirus (HPV) Vaccines Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus (HPV) Vaccines Product Picture
Figure 2. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. 2-Valent Vaccine Product Picture
Figure 4. 4-Valent Vaccine Product Picture
Figure 5. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Research & Academic Laboratories
Figure 7. Pharmaceutical & Biotechnology Companies
Figure 8. Others
Figure 9. Human Papillomavirus (HPV) Vaccines Report Years Considered
Figure 10. Global Human Papillomavirus (HPV) Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Human Papillomavirus (HPV) Vaccines Sales 2015-2026 (K Units)
Figure 12. Global Human Papillomavirus (HPV) Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Region in 2019
Figure 15. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region in 2019
Figure 17. Global Human Papillomavirus (HPV) Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Vaccines Revenue in 2019
Figure 19. Human Papillomavirus (HPV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type in 2019
Figure 22. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type in 2019
Figure 24. Global Human Papillomavirus (HPV) Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application in 2019
Figure 27. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application in 2019
Figure 29. North America Human Papillomavirus (HPV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Human Papillomavirus (HPV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Human Papillomavirus (HPV) Vaccines Sales Market Share by Country in 2019
Figure 32. North America Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country in 2019
Figure 33. U.S. Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Human Papillomavirus (HPV) Vaccines Market Share by Type in 2019
Figure 38. North America Human Papillomavirus (HPV) Vaccines Market Share by Application in 2019
Figure 39. Europe Human Papillomavirus (HPV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Human Papillomavirus (HPV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share by Country in 2019
Figure 42. Europe Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country in 2019
Figure 43. Germany Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Human Papillomavirus (HPV) Vaccines Market Share by Type in 2019
Figure 54. Europe Human Papillomavirus (HPV) Vaccines Market Share by Application in 2019
Figure 55. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share by Region in 2019
Figure 58. Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region in 2019
Figure 59. China Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Share by Type in 2019
Figure 82. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Share by Application in 2019
Figure 83. Latin America Human Papillomavirus (HPV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Human Papillomavirus (HPV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share by Country in 2019
Figure 86. Latin America Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country in 2019
Figure 87. Mexico Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Human Papillomavirus (HPV) Vaccines Market Share by Type in 2019
Figure 94. Latin America Human Papillomavirus (HPV) Vaccines Market Share by Application in 2019
Figure 95. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Market Share by Country in 2019
Figure 99. Turkey Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Human Papillomavirus (HPV) Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Human Papillomavirus (HPV) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Share by Type in 2019
Figure 106. Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Share by Application in 2019
Figure 107. North America Human Papillomavirus (HPV) Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Human Papillomavirus (HPV) Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Human Papillomavirus (HPV) Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Human Papillomavirus (HPV) Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Human Papillomavirus (HPV) Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Human Papillomavirus (HPV) Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Human Papillomavirus (HPV) Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…- ヒトパピローマウイルスタンパク質E6の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus Protein E6 Market The global Human Papillomavirus Protein E6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus Protein E6 Scope and Market Si…
- ヒトパピローマウイルスタンパク質E7の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus Protein E7 Market The global Human Papillomavirus Protein E7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus Protein E7 Scope and Market Si…
- ヒト用混合ワクチンの世界市場（～2026年） A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are eith…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …